Literature DB >> 27538763

Myrcludex B, a novel therapy for chronic hepatitis D?

Mario Rizzetto1, Grazia Anna Niro2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27538763     DOI： 10.1016/j.jhep.2016.06.014

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

1.  The effect of twelve weeks of treatment with ezetimibe on HDV RNA level in patients with chronic hepatitis D.

Authors:  Zaigham Abbas; Muhammad Saad; Muhammad Asim; Minaam Abbas; Shoukat Ali Samejo
Journal:  Turk J Gastroenterol       Date:  2020-02       Impact factor: 1.852

2.  Prevalence of hepatitis delta infections among HBs-antigen-positive inhabitants of southeastern and northwestern parts of Poland.

Authors:  Robert Pleśniak; Marta Wawrzynowicz-Syczewska
Journal:  Clin Exp Hepatol       Date:  2019-09-05

3.  Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients.

Authors:  Caroline Schmidbauer; David Chromy; Victor U Schmidbauer; Michael Schwarz; Mathias Jachs; David J M Bauer; Teresa Binter; Michael Apata; Dung T Nguyen; Mattias Mandorfer; Benedikt Simbrunner; Armin Rieger; Florian Mayer; Monika Breuer; Robert Strassl; Ralf Schmidt; Heidemarie Holzmann; Michael Trauner; Michael Gschwantler; Thomas Reiberger
Journal:  Liver Int       Date:  2021-08-05       Impact factor: 8.754

Review 4.  Hepatitis delta: virological and clinical aspects.

Authors:  Luan Felipo Botelho-Souza; Mariana Pinheiro Alves Vasconcelos; Alcione de Oliveira Dos Santos; Juan Miguel Villalobos Salcedo; Deusilene Souza Vieira
Journal:  Virol J       Date:  2017-09-13       Impact factor: 4.099
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.